Trial Profile
A 48-week, Randomised, Multi-centre, Openlabelled, Parallel-group Trial to Compare the Efficacy and the Safety of NN304 (Insulin Detemir) and NPH Human Insulin in Subjects With Insulin Requiring Diabetes Mellitus on a Basal-bolus Regimen.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 23 Jan 2012 Official Title amended as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual patient number (401) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual end date (1 Mar 2005) added as reported by ClinicalTrials.gov.